Critique of AI Drug Discovery Methodology and Technical Implementation

Current AI drug discovery efforts often prioritize adopting new technologies over verifying their specific utility for biological outcomes. Practitioners are cautioned to adopt moderate approaches to unproven techniques to avoid expensive, non-productive research cycles.